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Abstract 
Acid-sensing ion channels (ASICs) are neuronal Na+-selective ion channels that open in response 
to extracellular acidification. They are involved in pain, fear, learning and neurodegeneration 
after ischemic stroke. 2-Guanidine-4-methylquinazoline (GMQ) was recently discovered as the 
first nonproton activator of ASIC3. GMQ is of interest as a gating modifier and pore blocker of 
ASICs. It has however a low potency, and exerts opposite effects on ASIC1a and ASIC3. To 
further explore the molecular mechanisms of GMQ action, we have used the guanidinium moiety 
of GMQ as a scaffold and tested the effects of different GMQ derivatives on the ASIC pH 
dependence and maximal current. We report that GMQ derivatives containing quinazoline and 
quinoline induced, as GMQ, an alkaline shift of the pH dependence of activation in ASIC3 and 
an acidic shift in ASIC1a. Another group of 2-guanidinopyridines shifted the pH dependence of 
both ASIC1a and ASIC3 to more acidic values. Several compounds induced an alkaline shift of 
the pH dependence of ASIC1a/2a and ASIC2a/3 heteromers. Compared to GMQ, 
guanidinopyridines showed a 20-fold decrease in the IC50 for ASIC1a and ASIC3 current 
inhibition at pH5. Strikingly, 2-guanidino-quinolines and -pyridines showed a concentration-
dependent biphasic effect that resulted at higher concentrations in ASIC1a and ASIC3 inhibition 
(IC50 > 100 μM), while causing at lower concentration a potentiation of ASIC1a, but not ASIC3 
currents (EC50 ≈ 10 μM). In conclusion, we describe a new family of small molecules as ASIC 
ligands and identify an ASIC subtype-specific potentiation by a subgroup of these compounds.  
 
Acid-sensing ion channels (ASICs) are Na+-selective ion channels that are activated by a rapid drop in 
extracellular pH 1, 2. They form a sub-family of the ENaC /degenerin channel superfamily, to which 
besides ASICs the Epithelial Na+ channel ENaC, the C. elegans degenerins and the mollusk channel 
FaNaC belong 1. ENaC plays a role in transepithelial Na+ transport, the degenerins are part of a 
mechanotransduction complex, while FaNaC is a peptide-gated neuronal ion channel.  ASICs are 
mostly found in the nervous system, and their activation induces a membrane depolarization of the 
neurons in which they are expressed, affecting thereby neuronal signaling 3, 4. The subunits ASIC1a, -
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1b, -2a, -2b and -3 can assemble into homo- or heterotrimeric channels 5, 6. Biophysical properties of 
the ASICs, such as pH dependence and current kinetics, depend on the subunit composition, and it has 
been shown that ASIC1a is especially important in the central nervous system, while ASIC3 appears to 
be the most important ASIC subunit in the peripheral nervous system 1, 7. Studies with ASIC knockout 
mice provided evidence for roles of ASICs in learning, fear behavior, neurodegeneration after ischemic 
stroke, mechanosensation and pain sensation 1, 7-14. ASICs are therefore attractive potential targets for 
analgesic and anxiolytic drugs and for the pharmacological treatment of stroke. Positive allosteric 
modulators of ASICs may improve learning. The prototype ASIC inhibitor amiloride is used as a K+-
sparing diuretic due to its high affinity inhibition of ENaC15, 16. On ASICs, amiloride has however a low 
potency (IC50 of 10-100 µM, compared to 100 nM on ENaC 1). Amiloride concentrations required to 
inhibit ASIC currents affect also other transporters and ion channels17. In spite of efforts of several 
laboratories and drug companies, it seems that so far no clearly superior small molecule ASIC inhibitors 
have been discovered 1, 7, 18-22. In contrast, several toxins inhibit ASIC currents with nanomolar affinity 
23.  
For many years, protons were the only known activators of ASICs. In the search for other ASIC 
activators, a large number of ASIC modulators has been identified 1, 7. Such modulators, which are for 
example divalent and polyvalent ions, small molecules, and peptides, change in most cases the ASIC 
pH dependence 1, 7. Recently, the molecule 2-guanidine-4-methylquinazoline (GMQ) was shown to 
activate ASIC3 at physiological pH7.4 and to induce pain in an ASIC3-dependent manner, when 
injected into the paw of a mouse 24. Our laboratory has subsequently shown that GMQ induces ASIC3 
activation by changes in its pH dependence that create a window current at pH7.4. The GMQ-induced 
changes in ASIC3 pH dependence are different from the gating modulation by GMQ observed in other 
ASIC subtypes 25. GMQ can activate the ENaC/degenerin family member FaNaC, but has no effect on 
ENaC currents 26. It has also been shown that the endogenous arginine metabolites agmatine and arcaine 
exert similar effects on ASIC3 currents 27 as does GMQ. It is therefore possible that GMQ-like 
substances may be endogenous modulators of ASICs. GMQ contains, like amiloride, a guanidinium 
group. Interestingly, it was observed that GMQ inhibits ASICs by a pore block in addition to its effects 
on gating 25, and that at high concentrations, amiloride can affect the ASIC3 gating in a similar way as 
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does GMQ 28, 29. It would be interesting to better understand the molecular mechanisms of GMQ action 
and to use GMQ as a pharmacological tool in animal and cellular studies. Currently, the use of GMQ 
is limited by its low potency, with EC50 and IC50 values of the order of 2 mM 24, 25. The discovery of 
GMQ opened however the way for the design of new chemical entities modulating the dependence of 
ASIC activity on pH. 
The aim of the present study was to find GMQ analogs with improved affinity, and to understand the 
structure-activity relationship of GMQ-like compounds on ASICs. Among the derivatives tested, we 
identified groups with distinct effects on ASIC pH dependence. Most of the compounds showed also a 
strong inhibition of the maximal peak current of ASIC1a, but less of ASIC3. In ASIC1a/2a and 
ASIC2a/3 heteromers, the maximal current inhibition by these compounds was less pronounced, and 
shifts in pH dependence, if they occurred, were similar to those observed with ASIC3. Several 
compounds exerted a biphasic action on ASIC1a, inducing potentiation at concentrations of 10-80 µM, 
and inhibition at ≥ 100 µM.  
 
Results and Discussion 
Compound library and testing protocol 
ASIC activation by acidification leads only to a transient channel opening, because these channels 
desensitize rapidly (within hundreds of ms to s) after activation 1. ASICs can exist in three different 
functional states, closed, open and desensitized. The pH dependence of activation (Fig. 1a), the 
transition from the closed to the open state, determines the current induced by a solution change from 
pH7.4 to a given acidic pH. The pH that induces half of the maximal current amplitude (pH50) is 6.5-
6.7 for ASIC1a and ASIC3 30, 31. When ASICs are exposed for tens of seconds to a pH that is more 
acidic than pH7.4, but not sufficiently acidic to open them, they can enter the desensitized state without 
apparent opening, in a process called steady-state desensitization (SSD). The midpoint of SSD (pHD50) 
is ~7.2 for ASIC1a and ~7.1 for ASIC3 1. The pH dependence of SSD determines the availability of the 
channels for opening at a given basal pH. It was previously shown that GMQ shifts the pH dependence 
of activation of ASIC1a to more acidic, and that of ASIC3 to more alkaline values, as illustrated 
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schematically in Fig. 1a 25, 29. Due to an additional acidic shift of the pH dependence of SSD in ASIC3, 
GMQ induces a sustained (i.e. a non- or partially desensitizing) current at pH ≥ 6 in this ASIC subtype 
25. In addition, GMQ decreases the maximal current amplitude induced by acidification to pH5 due to 
its pore-blocking effect (Fig. 1a)25. To characterize the effects of GMQ derivatives, the current response 
was measured at pH6.6 to detect effects on pH dependence (“gating effect”), and at pH5, where the 
current is maximal, to quantify the pore block (“blocking effect”), as illustrated in Fig.1a with the 
hypothetical pH dependence curves of ASIC1a and ASIC3 in the absence or presence of a GMQ 
derivative. Experiments were carried out with CHO cell lines stably expressing human ASIC1a 32 or rat 
ASIC3 30, at compound concentrations of 0.3 and 1 mM. Typical current traces obtained under such 
conditions in the absence and presence of the GMQ derivatives 5a in ASIC1a and 7, as well as 4a in 
ASIC3, are shown in Fig. 1b. A sustained current was induced by compound 4a (Fig.1b, bottom panel; 
the compounds used in this study are shown in Fig. 2). The ASIC3 current increase at pH6.6 in the 
presence of compound 7 (Fig. 1b, middle panel) indicates an alkaline shift in pH dependence. An 
inhibition of the pH5-induced current was observed with all three compounds shown in Fig. 1b. 
The initial analysis of the structure-activity relationship of GMQ by Yu et al.24 was limited to the 2-
guanidino-4-methylquinazoline scaffold, since 2-guanidino-benzimidazole, -benzothiazole and 
benzoxazole were found to modulate ASIC3 poorly or not at all. In the present study, we modified the 
quinazoline scaffold of GMQ (Fig. 2). In a first series (cluster #1), we conserved the bicyclic system of 
GMQ, but we replaced the benzene ring by a cyclohexene ring (1) to evaluate the influence of the 
aromatic ring on activity. We also synthesized quinoxaline (2) and quinoline (3a, b) bicycles as GMQ 
analogs, in order to evaluate the role of the methyl group at position 4, but more importantly because 
the removal of the nitrogen atom at position 3 of GMQ limits the formation of an H-bond interaction 
with guanidine to the nitrogen atom at position 1. In a second series, we disconnected both rings to 
generate the 6, 5, and 4-phenyl-2guanidinopyridines, forming clusters #2 (4a-c), #3 (5a-e), and #4 (6), 
respectively. Finally, we investigated the loss of the guanidine moiety with the 2-aminopyridines 7 and 
8 (cluster #5).  
 
Blocking effect of GMQ and its derivatives on ASIC1a at pH5 
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At pH5 and a concentration of 1 mM, GMQ inhibited the maximal current of ASIC1a (IGMQ/Ictrl = 0.68 
± 0.06 at pH5; n=7, p<0.01; Fig.3a, filled bars). Compound 1 showed no significant inhibition (Icpd/Ictrl 
= 0.81 ± 0.10, p>0.05), while quinoxaline 2, as well as the quinoline 3b, showed a similar modest 
inhibition as GMQ. Quinoline 3a, however, produced a stronger inhibition than GMQ (Icpd/Ictrl = 0.26 
± 0.13, p<0.01vs. GMQ). This suggests that the nitrogen atom at position 3 of GMQ alters the blocking 
effect on ASIC1a. Interestingly, all the guanidinopyridine analogs (clusters #2, #3, and #4) showed a 
blocking effect on ASIC1a that was similar or even greater than that by GMQ. While the presence of 
an aryl group at position 6 of the pyridine did not change the blocking effect (4a-c), aryl groups at 
position 3 (5b-c) or 4 (6) led to efficient pore blockers with Icpd/Ictrl ratios of 0.24 ± 0.08 (p<0.01), 0.16 
± 0.11 (p<0.0001), and 0.22 ± 0.02 (p<0.001), respectively. Finally, the two compounds lacking the 
guanidine moiety, 5-phenyl-2-aminopyridine (7) and 6-phenethyl-2-aminopyridine (8) showed a 
moderate inhibition quite similar to the one by GMQ.  
 
Gating effect of GMQ and its derivatives on ASIC1a at pH6.6 
The pH50 of ASIC1a and ASIC3 activation is ~6.5 and ~6.7, respectively 1, 7, 25. Modulatory effects of 
test compounds on the ASIC pH dependence were measured at pH6.6 (Fig. 3a, open bars). Because 
pH6.6 is within the steep range of the pH – current relationship (Fig. 1a), the pH6.6-induced current is 
very sensitive to changes in pH dependence. GMQ at 1 mM abolished the pH6.6-induced current of 
ASIC1a (“gating effect”, IGMQ/Ictrl = 0.03 ± 0.01), while reducing the pH5-induced peak amplitude 
(“blocking effect”) by ~30%. With compounds that induce an inhibition of the maximal current 
amplitude (filled bars in Fig. 3a), an Icpd/Ictrl ratio at pH6.6 (open bars) that is smaller than the 
corresponding ratio at pH5 indicates an acidic shift of the pH dependence due to the tested compound, 
while an Icpd/Ictrl ratio at pH6.6 higher than that at pH5 indicates an alkaline shift. Based on these ratios 
at pH5 and pH6.6, and under the assumption that the compounds did not change the steepness of the 
pH – current relationship, we estimated the shift of pH50 (DpH50) for the activation curve of each 
compound in comparison with the control condition (Fig 3b, (DpH50 > 0: alkaline shift; DpH50 < 0: 
acidic shift; see Methods). Fig. 3b indicates thus the estimated shifts in pH dependence induced by the 
different compounds.  
GMQ and its analogs, except for 4a-b, 6 and 7, produced Icpd/Ictrl ratios at pH6.6 that were significantly 
different from the Icpd/Ictrl ratio measured at pH5.0. Based on this comparison we can conclude that these 
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compounds significantly shift the ASIC1a pH dependence. GMQ analogs from cluster #1 (yellow bars 
in Fig. 3, bicycles 1, 2, 3a, 3b), as well as cluster #3 (red bars, 5-substituted pyridines 5a-e) have thus 
a qualitatively similar profile as GMQ, inducing an acidic shift of the pH50. Of the 6- and 4-substituted 
pyridines from cluster #2 (green bars) and #4 (purple bar) respectively, only 4c induced a modest shift 
in pH50, similarly as compounds from cluster #1 (1-3). The aminopyridine 8 (cluster #5) was the only 
compound to produce an alkaline shift in ASIC1a. 
 
Blocking effect of GMQ and its derivatives on ASIC3 at pH5 
At pH5 and a compound concentration of 1 mM, GMQ did only slightly decrease the maximal peak 
current of ASIC3 (IGMQ/Ictrl = 0.83 ± 0.07, n=8; Fig.4a). Indeed, it had previously been shown that higher 
GMQ concentrations are needed to efficiently inhibit the pH5-induced ASIC3 current (IC50 = 6.74 ± 
0.83 mM) 25. Compounds 1 and 2 showed no inhibitory activity at 1 mM (p>0.05), whereas both 
quinolines (3a and 3b) showed a significant blocking effect with Icpd/Ictrl ratios of 0.37 ± 0.03 and 0.59 
± 0.03, respectively (p<0.0001 and <0.001, n=4). This result indicates that the substitution of the 
nitrogen atom at position 3 of GMQ alters the blocking effect on ASIC3, while the methyl group at 
position 4 has no influence. Interestingly, all the guanidinopyridines from clusters #2, #3, and #4, led 
to efficient inhibition of ASIC3 at 1 mM with Icpd/Ictrl ratios ranging from 0.16 ± 0.02 (6, n = 5) to 0.44 
± 0.05 (5a, n=5). In contrast, the presence of a phenethyl group at position 5 led to less efficient pore 
block (5e vs 5d p<0.05). Finally, the compounds 7 and 8, lacking a guanidine moiety (cluster #5), 
showed only a modest blocking. 
 
Blocking effects of GMQ derivatives 
The inhibition experiments at pH5 show that at 1 mM, GMQ and its derivatives belonging to cluster #1 
were mostly poor inhibitors of both channels. The quinolines 3a and 3b showed stronger inhibition than 
GMQ on ASIC3, and 3a on ASIC1a, illustrating the contribution of the nitrogen atom at position 3. In 
addition, most of the guanidinopyridines (clusters #2-4) led to a substantial inhibition of both channels. 
Interestingly, this inhibition seems to be independent of the position of the substituents on the pyridine 
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ring, or of the pKa of the molecules (Table S1). Finally, 2-aminopyridines (cluster #5) were poor 
inhibitors of both channels. 
 
Gating effect of GMQ and its derivatives on ASIC3 at pH6.6  
At pH6.6 and a concentration of 1 mM, GMQ increased the ASIC3 current (IGMQ/Ictrl = 1.26 ± 0.09 at 
pH 6.6), consistent with a shift of the activation curve to a more alkaline value (Fig 4a). As for ASIC1a, 
an estimate of the shift in pH50 induced by each of these compounds, based on the peak current ratios 
at pH 5 and 6.6, is presented in Fig. 4b (DpH50 > 0: alkaline shift; DpH50 < 0: acidic shift). Bicyclic 
analogs from cluster #1, except quinoxaline 2, tend to shift the pH50 to alkaline values on ASIC3, in an 
opposite manner to their shifts on ASIC1a. All 5-substituted guanidinopyridines (5a-e) showed a 
tendency of, or a significant acidic pH50 shift (5b, 5c, 5e), with DpH50 values ranging from -0.05 to -
0.22. In contrast to compounds of cluster #1, compounds of cluster #3 induced an acidic pH50 shift (or 
a tendency of) in both channels. Finally, both 2-aminopyridines (7 and 8) induced an alkaline pH50 shift. 
 
Gating effects of GMQ derivatives 
Whereas the position of the substitution on the pyridine ring was not crucial for the inhibitory effect at 
pH5, it was clearly important for the shift in pH dependence. Depending on the position of the aryl 
group on the pyridine ring, we observed no shift (clusters #2 and #4), an alkaline shift in ASIC3 and an 
acidic shift in ASIC1a (cluster #1), or a shift to more acidic values in both ASIC subtypes (cluster #3). 
This dependence of the gating effect on the position of the aryl group suggests that the position of the 
aromatic group on the guanidinopyridine may be critical for the interaction with the modulatory GMQ 
binding site. Finally, the 2-aminopyridine 8 was the only tested compound to induce an alkaline shift 
in ASIC1a. 
 
Do GMQ derivatives induce a sustained ASIC3 current?  
GMQ is known to generate a sustained current in ASIC3 with maximal amplitudes in the pH range 6.5-
7 25. We evaluated the capability of GMQ derivatives to generate a similar effect. The sustained current 
amplitude, measured at pH6.6 in the presence of 1mM of the compound, was normalized in two ways 
(Fig. 4c). First, this sustained current was normalized to the maximal acid-induced current in the 
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absence of the compound, as Isust(pH6.6, cpd)/Ipeak(pH5, ctrl) ratio (Fig. 4d, filled bars). As an indication of the 
shape of the current, the Isust(pH6.6, cpd)/Ipeak(pH6.6, cpd) ratio, which compares the amplitude of the sustained 
current with the amplitude of the peak current induced by the test compound at pH6.6, is provided as 
open bars in Fig. 4d. For GMQ, these two ratios were similar (0.36 ± 0.05 vs 0.60 ± 0.02), since the 
pH6.6-induced peak current amplitude in the presence of 1 mM GMQ is only slightly smaller than the 
pH5-induced peak current amplitude under control conditions. In the absence of any compound, no 
sustained current was measured at pH6.6, and both ratios were 0.01 ± 0.01 (n=16). In most derivatives 
tested, the shape of the current was conserved with regard to GMQ, as indicated by similar Isust(pH6.6, 
cpd)/Ipeak(pH6.6, cpd) ratios (open bars). Only the 2-aminopyridines 7 and 8 from cluster #5 did not induce 
any sustained current. The Isust(pH6.6, cpd)/Ipeak(pH5, ctrl) ratios (filled bars in Fig. 4d) were however 
considerably smaller than what had been observed with GMQ. The difference in the two ratios is 
essentially due to the strong current block observed with most GMQ derivatives other than guanidino-
quinazolines (Fig. 4a). A substantial Isust(pH6.6, cpd)/Ipeak(pH5, ctrl) ratio was only observed with the monocycle 
2-guanidino5-phenyl-pyridine 5a and with some compounds of cluster #1. Together, this suggests that 
the mechanism underlying the formation of this sustained current is very sensitive to the chemical 
structure of the modulator, and is also affected by the inherent inhibitory effect of the modulator. In the 
presence of GMQ, the activation and SSD curves of ASIC3 cross each other at a pH of ~6.8-7.0. The 
pH dependence of the sustained ASIC3 current amplitude under these conditions forms a bell-shaped 
curve that has its maximum at the crossing of these two curves, consistent with it being a window 
current 25, 29. Analysis of the amplitude of the sustained ASIC3 current in the presence of selected GMQ 
derivatives at several pH conditions shows maximal sustained current amplitudes at pH 7 or 6.6 (Fig. 
S1), further supporting that these compounds also induce a window current in ASIC3, as does GMQ.  
There was no indication of sustained ASIC1a currents in the presence of GMQ derivatives, in agreement 
with previous observations with GMQ 25, 29.  
 
Concentration dependence of ASIC current inhibition at pH5 by GMQ derivatives 
All experiments described above were carried out at two compound concentrations, 1 and 0.3 mM, as 
documented for the pH5-induced current in Table S2. Comparison of the effects at the two 
concentrations suggested an increased potency relative to GMQ of some of the test compounds. To 
confirm the predicted change in IC50 of current inhibition at pH5 of some of the GMQ derivatives, 
inhibition curves were recorded for the 5-phenylpyridine 5a and its two derivatives 5b and 5c, on 
ASIC1a and ASIC3 (Fig. 5). This showed that in both ASIC1a and ASIC3, these three compounds 
inhibit currents at lower concentrations than does GMQ. IC50 values were 3.3±0.8 mM (ASIC1a) and 
7.4±1.1 mM (ASIC3) for GMQ, 0.53±0.07 and 0.58±0.11 mM for 5a, 0.47±0.28 and 0.23±0.08 mM 
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for 5b and 0.19±0.01 and 0.27±0.04 mM for 5c (n=3-6). This up to 20-fold increase in potency relative 
to GMQ was significant for 5c in ASIC1a, and for 5b and 5c in ASIC3 (p<0.01).  
 
Modulation of heteromeric ASIC currents by GMQ derivatives 
In the central nervous system, functional ASICs are mostly ASIC1a homomers, ASIC1a/2a heteromers 
and ASIC1a/2b heteromers, while in the peripheral nervous system most functional ASICs are 
heteromers of various compositions 1, 7, 33. To expand our analysis, we determined the effect of selected 
compounds at a concentration of 1 mM on two different ASIC heteromers, ASIC1a/2a, representative 
of a central nervous system ASIC, and ASIC2a/3, representative of a peripheral nervous system ASIC. 
Heteromeric ASICs adapt a flexible  stoichiometry that depends on the subunit availability, as shown 
for ASIC1a/2a 5.  The inclusion of ASIC2a subunits shifts the pH50 to more acidic values, in the range 
of pH5.5 – pH6 for both ASIC1a/2a and ASIC2a/3 34, 35. Measurements addressing the shift in pH 
dependence (“gating effect”) were therefore carried out at pH5.8, while testing for effects on the 
maximal current amplitude (“blocking effect”) was done at pH4. An IpH5.8/IpH4.0 ratio close to ~0.5 
served as an indication that the investigated currents were indeed mediated by heteromeric channels 
(Table S3). In ASIC1a/2a, only about half of the tested compounds induced amplitude changes that 
were significantly different between pH5.8 and 4 and indicated thus a shift of the pH dependence (Fig. 
6a). With GMQ, 4a and 6, the Icpd/Ictrl ratio was greater at pH5.8 than at pH4, indicating therefore an 
alkaline shift of the pH dependence of activation, opposed to what we had observed with ASIC1a 
homomers.  The absence of shifts in pH dependence by many, and the predicted alkaline shift by GMQ, 
4a and 6 in the ASIC1a/2a heteromers may be explained by the previously documented opposite GMQ-
induced shifts of the activation pH dependence in ASIC1a and ASIC2a 25. In ASIC2a/3 heteromers, 
several compounds showed a tendency of increased Icpd/Ictrl ratios at pH5.8 over pH4. These differences 
were however only significant for 4a and 8 (Fig. 6b). We observed a high cell-to-cell variability of the 
Icpd/Ictrl, and also a variability of the IpH5.8/IpH4 ratio in the absence of any compound, which indicates 
differences of the ASIC2a:ASIC3 ratio of these heteromers. Interestingly, the potentiation of the pH5.8-
induced current by compounds 3a and 4a was greater in cells with a low IpH5.8/IpH4 ratio, thus in cells 
with an important contribution of ASIC2a (Fig. S2).   
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Only few compounds affected the IpH4 amplitude in the heteromers, suggesting that the inclusion of 
ASIC2a may distort the GMQ binding site for blocking. Taken together, heteromers with ASIC2a are 
generally less modulated by GMQ and its derivatives than the ASIC1a and ASIC3 homomers. Some 
compounds however exert strong effects on the heteromers. No acidic shifts in pH dependence were 
induced in the heteromers, showing that the response of heteromers to GMQ and its derivatives is closer 
to that of ASIC3 than ASIC1a.  
 
Potentiation of ASIC1a and ASIC heteromer currents by GMQ derivatives at low concentrations  
Whereas most of the tested GMQ derivatives led to an inhibition of both ASIC1a and ASIC3 pH5-
induced currents at sub-millimolar concentrations, we observed that at a lower concentration (< 100 
µM), compounds of several clusters induced an unexpected potentiation of the pH6.6-induced ASIC1a 
current (Fig. 7). The quinazoline GMQ did not potentiate ASIC1a currents, whereas its quinoline 
analogs 3a and 3b showed a significant potentiation (of ~50%) of the current at 30µM. This potentiation 
effect was even observed at 10 µM with the 4- and 6-phenylpyridines 6 and 4a, whereas the 5-
phenylpyridine 5a induced only a very small potentiation at 10 µM and none at 30 µM. The ASIC 
inhibitor amiloride did not induce any potentiation at 10 and 30 µM. A possible potentiation by 
amiloride might be hidden by its substantial pore block at this concentration 15, 19. At lower 
concentrations that do not inhibit ASIC1a, amiloride had however no effect on ASIC1a currents (Fig. 
7). No such effect was observed with any of the tested compounds at 10-30 µM on ASIC3 (Fig. S3a) 
or ASIC1a/2a (at pH5.8, Fig. S3b). In ASIC2a/3, GMQ induced at these concentrations a small 
inhibition, and 5a induced a strong potentiation (Fig. S3c). A further analysis of the potentiation effects 
on ASIC1a was then carried out with compound 6. The EC50 for increasing the current amplitude was 
9.4 ± 5.4 µM (error of the fit, n=3-8), while the IC50 of inhibition was 93.4 ± 0.4 µM (n=4, Fig. 8a). To 
test whether the current increase was due to a change in pH dependence, we measured the pH 
dependence of activation and of SSD of ASIC1a and ASIC3 in the absence and the presence of 30 µM 
6. Compound 6 did not affect the pH50 values of activation or desensitization, it changed however the 
steepness of the pH dependence curves, rendering the ASIC1a activation curve steeper, and both curves 
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of ASIC3 less steep (Fig. 8b-c, Table S4). These changes can only partially explain the observed current 
increase in ASIC1a. We observed however also a slowing of the desensitization time course of ASIC1a 
(Fig. 8d). This indicates that the transition into the desensitized state is slowed in the presence of 30 
µM compound 6, which will increase the current amplitude, and will contribute to the ASIC1a current 
potentiation. The kinetics of current appearance showed no apparent change in the presence of 
compound 6 (Fig. 8d). In our whole-cell experiments, the kinetics of current appearance are however 
limited by the speed of perfusion change (Methods), which is slower than channel opening 36, and we 
can therefore not draw conclusions about the opening kinetics.  
Potentiating ASIC currents may be of interest in some instances, for example for increasing synaptic 
transmission or the induction of LTP 7. For such applications, GMQ derivatives with only a small 
blocking effect, such as those of cluster #2, would be more suitable than compound 6. 
The biphasic effect of GMQ on ASIC3 24, 25, and of these compounds on ASIC1a currents likely reflects 
binding to at least two binding sites, a modulatory and an inhibitory site, with different affinities, as 
previously suggested 25, 37. We have shown that the inhibition of ASIC1a and ASIC3 currents at pH5 
by GMQ was due to a pore block, since it decreased unitary current amplitudes and was affected by a 
mutation in the pore25. Based on molecular docking, site-directed mutagenesis and the measurement of 
GMQ-induced current at pH7.4, a detailed description of a GMQ binding site in the palm domain of 
ASIC3 has been provided 38, which is therefore a strong candidate for the “gating” binding site. A later 
analysis showed however that mutation of some residues suggested to be central for GMQ binding in 
the palm suppressed the GMQ-induced shift of the pH dependence of SSD, but not that of activation 25. 
This suggested that either the individual mutations of palm residues cannot sufficiently disrupt GMQ 
binding, or that these mutations do not affect the GMQ binding itself, but rather the consequences of 
binding. The low apparent affinity of GMQ precludes a more precise analysis of its binding site. The 
GMQ derivatives with higher affinity than GMQ will allow studies that aim at identifying the precise 
GMQ binding site(s). This will help elucidating the activation mechanism of ASICs, and the 
development of more potent and specific ASIC modulators. 
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Recombinant expression of ASICs in Chinese hamster ovary (CHO) cells 
CHO cell lines stably expressing human ASIC1a or rat ASIC3 had been established as indicated 
elsewhere 39, based on the human ASIC1a clone of the Corey laboratory 32, and the rat ASIC3 clone of 
the Lazdunski laboratory 30. Heteromeric ASICs were expressed by transient co-transfection of the 
above mentioned ASIC1a and ASIC3 cDNAs together with ASIC2a cDNA. The protein sequence of 
the human ASIC2a clone used here 32, is 99% identical with the rat ASIC2a clone. Transfections were 
carried out with ASIC clones in the peak8 expression vector (Edge Biosystems, Gaithersburg, MD), 
together with a green fluorescent protein construct, by using Roti-Fect (Carl Roth, Karlsruhe, 
Germany). The cDNA ratios for the transfections was 1:1 for ASIC1a/ASIC2a heteromers and 2:1 for 
ASIC2a/ASIC3 heteromers. The measured IpH5.8/IpH4 ratios confirmed that the expressed channels 
were heteromeric (Table S3). 
 
Electrophysiology 
Electrophysiological measurements were carried out in the whole-cell patch-clamp mode at -60 mV 
with an EPC9 or EPC10 amplifier (HEKA Electronics, Lambrecht, Germany) and data acquisition was 
done with the Patchmaster software. Data were acquired at a sampling rate of 1 ms and filtered at 3 
kHz. Pipettes were pulled from borosilicate glass (World Precision Instruments, Stevenage, UK). They 
had resistances of 2-5 MΩ when filled with the pipette solution. Series resistance compensation was set 
to 70-95%. The extracellular recording solution contained, in mM, NaCl 140, KCl 4, CaCl2 2, MgCl2 
1, 4-morpholineethanesulfonic acid (MES) 10, HEPES 10, Glucose 10. The pH was adjusted to the 
desired value with NaOH. Conditioning solution (applied between acidifications) had a pH of 7.4. Fast 
solution changes were carried out with a MPRE8 perfusion head (Cell Micro-Controls, Norfolk, VA) 
and computer-controlled electrovalves from either Cell Micro-Controls or Biologic (Claix, France). The 
speed of the perfusion change at the cells was determined on the sustained component of the ASIC3 
current at pH7.0 by measuring the kinetics of the change in current amplitude when the perfusion 
solution was changed between the standard extracellular solution containing 140 mM Na+ and a solution 
in which the Na+ was replaced by the larger, ASIC-impermeable cation NMDG+.  The (10% to 90%) 
rise time of the solution change was 210 ± 20 ms, n=6. The pipette solution contained, in mM, K-
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gluconate 90, KCl 10, NaCl 10, MgCl2 1, HEPES 60, EGTA 10, and its pH was adjusted to 7.3 with 
KOH. Data were analyzed with Fitmaster (HEKA). The compounds were included in the acidic 
extracellular solution (pH6.6 and pH5), and the pH of the solution was verified after addition of the 
compound, and adjusted if necessary. 
 
Analysis and Statistics 
Normalized activation curves (pH dependence of peak current amplitudes) were fitted to the Hill 
equation I=Imax/(1 + (10−pH50/10−pH)nH), where Imax is the maximal current amplitude, pH50 is the value at 
which the current amplitude is half-maximal and nH is the Hill coefficient. SSD curves were fitted to 
an analogous equation to obtain the pHD50 values. Data are presented as mean ± SEM. To determine 
significance of differences in multiple comparisons we used two-way ANOVA followed by post-hoc 
Tukey test. To determine whether the amplitude change by a given compound was significant, we used 
a paired t-test (Graphpad Prism 7 and Microsoft Excel). 
To estimate pH50 shifts from current ratios at pH6.6, currents were expressed as a function of pH50 and 
nH by using the Hill equation, using nH values for the control situation previously measured in control 
conditions for each of the two subtypes, and the pH50 calculated for each condition from the measured 
current amplitudes induced by pH6.6 and 5.0 in the absence of compound. The ratio I(compound, pH6.6) / 
I(control, pH6.6) was then calculated based on these equations, and pH50(compound) was adjusted, while 
keeping nH unchanged, until the calculated I(compound, pH6.6) / I(control, pH6.6) ratio matched the experimental 
value of a given compound and ASIC subtype. The shift in pH50 was then calculated as 
pH50(compound)-pH50(control). In three cases with ASIC3 (marked as open bars in Fig. 4b), the 
measured I(compound, pH6.6) / I(control, pH6.6)  ratio was greater than the theoretically possible value, most likely 
because the compound also induced a change in the Hill coefficient. For these cases we plot in Fig. 4b 
the DpH50 corresponding to 95% of the maximal theoretical I(compound, pH6.6) / I(control, pH6.6) ratio.  
 
Substances 
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The compounds were synthesized as described in the Supporting Information. GMQ was purchased 
from Sigma. Stock solutions of compounds were made in DMSO at 100 mM. Final concentrations of 
DMSO were maximally 1%. 
 
Supporting information 
Three supplemental figures, showing 1) sustained current amplitudes of ASIC3 at various pH values, 
2) a correlation of compound effects with relative subunit expression, and 3) current ratios in cells 
expressing ASIC3 or heteromeric ASICs; 4 supplemental tables, containing 1) pKa values of 
compounds, 2 & 3) current ratios, 4) pH dependence parameters; a methods section describing in detail 
the compound synthesis. 
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Figure 1. Principle of compound testing. a, Hypothetical pH dependence of activation is shown for 
ASIC1a and ASIC3 in the absence of a test compound (solid black line), and in the presence of a 
compound with similar properties as GMQ on ASIC3 (green dashed line) and ASIC1a (orange dashed 
line), showing the change in pH dependence and maximal current amplitude. The arrows indicate the 
changes in current amplitude measured at pH6.6 (“gating effect”) and pH5 (“blocking effect”). b, Traces 
of a representative experiment with compound 5a on ASIC1a (top) and compounds 7 (center) and 4a 
(bottom) on ASIC3 at concentrations of 0.3 and 1 mM. ASICs were expressed in CHO cells and their 
currents were measured with whole-cell patch-clamp. 
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Figure 2. GMQ derivatives tested. Structures of the different compounds tested in this study are 
shown, and the clusters are identified.  
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Figure 3. Functional analysis of GMQ derivatives on ASIC1a. a, Bar graph indicating the peak current 
amplitudes induced with pH5 (filled bars) or pH6.6 (open bars), in the presence of 1 mM test compound, 
normalized to the current amplitude measured at the same pH in the absence of the compound. b, Shift 
of the pH dependence of activation by different compounds, estimated from comparison of the Icpd/Ictrl 
ratios at pH6.6 and pH5 (see Methods). Significance indications are p<0.05, 0.01, 0.001 and 0.0001, 
respectively for 1, 2, 3, or 4 symbols, in a, * inhibition at pH5 or change in amplitude at pH6.6; # effect 
of compound different from GMQ effect; in b, §, difference between the Icpd/Ictrl ratio at pH5 and pH6.6 
for a given compound (n=3-10).  
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Figure 4. Functional analysis of GMQ derivatives on ASIC3. a, Bar graph indicating the peak current 
amplitudes induced with pH5 (filled bars) or pH6.6 (open bars), in the presence of 1 mM test compound, 
normalized to the current amplitude measured at the same pH in the absence of the compound. b, Shift 
of the pH dependence of activation by different compounds, estimated from comparison of the Icpd/Ictrl 
ratios at pH6.6 and pH5 (see Methods). The open bars represent values calculated in a different way 
(Methods). c, Representative current traces of ASIC3 obtained either by pH6.6 together with 1mM of 
the compound 4a (top), or by a control application of pH 5.0 (bottom) from the same cell, to illustrate 
the two ways of Isust normalization. The dotted red vertical lines represent the different amplitudes. The 
arrows indicate the ratio represented in d by the open bars (Isust pH6.6, 1mM / Ipeak pH6.6, 1mM) and 
the filled bars (Isust pH6.6, 1mM / Ipeak pH5.0, ctrl).   d, Bar graph plotting the sustained current amplitude 
induced with 1 mM test compound at pH6.6, normalized either to the peak current induced by pH5 in 
absence of the compound (filled bars) or the pH6.6-induced peak current in the presence of the 
compound (open bars; “shape”). Compounds 5b and 5d at 1 mM destabilized the recording when 
applied for >5s. Therefore, the sustained current could not be measured in the presence of 5b and 5d. 
Significance indications are p<0.05, 0.01, 0.001 and 0.0001, respectively for 1, 2, 3, or 4 symbols, in 
panel a, * inhibition at pH5 or change in amplitude at pH6.6; # effect of compound different from GMQ 
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effect; in b, §, difference between the Icpd/Ictrl ratio at pH5 and pH6.6 for a given compound; in d, #, Isust 
/Ipeak ratio different from that of GMQ; n=3-10.  
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Figure 5. Inhibition curves by selected compounds. The indicated compounds were included at 
different concentrations in the stimulation solution of pH5. Current amplitudes measured with 
compound were normalized to the amplitude obtained in the absence of the modulator. Data are from 
3-6 experiments per compound, shown for ASIC1a (a) and ASIC3 (b). Inhibition curves were fitted to 
a Hill equation, and IC50 values are presented in the text. 
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Figure 6. Functional analysis of GMQ derivatives on ASIC1a/2a and ASIC2a/3. a, b, Bar graphs 
indicating the peak current amplitudes induced with pH4 (filled bars) or pH5.8 (open bars), in the 
presence of 1 mM test compound, normalized to the current amplitude measured at the same pH in the 
absence of the compound, for ASIC1a/2a heteromers (a) and ASIC2a/3 heteromers (b). Significance 
indications are p<0.05, 0.01, 0.001 and 0.0001, respectively for 1, 2, 3, or 4 symbols; *, change in 
amplitude by the compound at pH4 or 5.8; #, effect of compound different from GMQ effect; §, 
difference between the Icpd/Ictrl ratio at pH4 and pH5.8 for a given compound (n=3-7).  
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Figure 7. Potentiation of ASIC1a currents by selected GMQ derivatives. ASIC1a currents were induced 
by pH6.6 with or without test compound. The indicated concentrations of the test compounds were 
included in the pH6.6 solution. The current amplitude obtained in the presence of a test compound was 
normalized to the amplitude obtained in its absence. Data were obtained from 3-7 cells per condition *, 
p<0.05, **, p<0.01, ***, p<0.001 between test and control condition, paired t-test. 
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Figure 8. Analysis of ASIC1a current potentiation by compound 6. a, ASIC currents were induced by 
acidification to pH6.6 either under control conditions, or with increasing concentrations of compound 
6 included in the pH6.6 solution and were normalized to the pH6.6-induced peak current amplitude in 
the absence of the compound. The concentration-dependent inhibition of ASIC3 currents (green, solid 
squares), the appearance of a sustained ASIC3 current (open green squares), and the biphasic effect on 
ASIC1a (red circles) are shown. The data were fitted to Hill equations; for ASIC1a, a combined 
equation was used. Fit parameters for ASIC1a are presented in the text. ASIC3 peak current inhibition 
IC50 = 153.7 ± 20.4 µM, n = 3-6; ASIC3 sustained current EC50 = 55.2  ± 29.5 µM, n = 3-6). b and c, 
Activation and steady-state desensitization curves obtained under control conditions (open symbols) 
and in the presence of 30 µM compound 6 (filled, colored symbols), for ASIC1a (b) and ASIC3 (c). 
The fit parameters are shown in Table S4. d, Left, representative current traces of ASIC1a induced by 
pH6.6 in the absence or presence of 30 µM 6. The traces were normalized to allow comparison of the 
kinetics. Right, time constants of opening and desensitization (current decay) of pH6.6-induced current 
in the absence (open bars) or presence (red) of 30 µM 6, n=8. **, p<0.01. 
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